Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 211

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction

Koch-Weser, Jan, Frishman, William H., Furberg, Curt D., Friedewald, William T.·1984·New England Journal of Medicine

Abstract

THE β-adrenoceptor antagonists have been shown to be both safe and effective for the treatment of systemic hypertension, arrhythmia, angina pectoris, hypertrophic cardiomyopathy, thyrotoxicosis, and open-angle glaucoma, and for prophylaxis against migraine headache.1 Recent clinical trials with one to four years of active treatment have demonstrated that some orally active β-blockers can reduce the risk of cardiovascular mortality in patients recovering from acute myocardial infarction.2 3 4 5 6 7 8 9 10 11 12 13 14 15 On the basis of the results of the Norwegian Multicenter Study10 and the Beta-Blocker Heart Attack Trial11 in North America, the Food and Drug Administration has recently approved two nonselective β-blockers, timolol maleate (Blocadren) and . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm198403293101306

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 211

Metadata

Authors
Koch-Weser, J., Frishman, W. H., Furberg, C. D., & Friedewald, W. T.
Venue
New England Journal of Medicine
Published
1984-03-29
Volume
310
Issue
13
Pages
830-837
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2094022692
Cited by
211
References
1
FWCI
13.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction. https://app.cochat.ai/papers/10.1056/nejm198403293101306
The paper
Koch-Weser, J., Frishman, W. H., Furberg, C. D., & Friedewald, W. T. (1984). β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction. New England Journal of Medicine. https://doi.org/10.1056/nejm198403293101306

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.